Balyasny Asset Management L.P.

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1218710 Chicago, IL

Back to IOVA Full portfolio

Position in IOVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,552,861

+$679,700 QoQ

Shares Held

373,284

+50.1% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 292 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Dec 31, 2024

CallValue

$5,180,000

CallShares

700,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. IOVA ranks #113 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

All Filings in IOVA

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,552,861	373,284	+50.1%	Shares	Sole	2026-08-14
2026-03-31	$873,161	248,764	+265.6%	Shares	Sole	2026-05-15
2025-12-31	$185,743	68,038	-24.9%	Shares	Sole	2026-02-17
2025-09-30	$196,654	90,624	-94.0%	Shares	Sole	2025-11-14
2025-06-30	$2,593,385	1,507,782	+618.2%	Shares	Sole	2025-08-14
2025-03-31	$699,103	209,941	-92.6%	Shares	Sole	2025-05-15
2024-12-31	$20,866,512	2,819,799	-37.0%	Shares	Sole	2025-02-14
2024-12-31	$5,180,000	700,000	+75.0%	Call	Sole	2025-02-14
2024-09-30	$41,997,488	4,472,576	-1.5%	Shares	Sole	2024-11-14
2024-09-30	$3,756,000	400,000	-72.0%	Call	Sole	2024-11-14
2024-06-30	$36,415,291	4,540,560	+278.1%	Shares	Sole	2024-08-14
2024-03-31	$17,796,804	1,200,864	-69.4%	Shares	Sole	2024-05-13
2023-12-31	$31,919,672	3,926,159	-12.3%	Shares	Sole	2024-02-14
2023-09-30	$20,369,603	4,476,836	+190.7%	Shares	Sole	2023-11-14
2023-09-30	$6,506,500	1,430,000	+1000.0%	Call	Sole	2023-11-14
2023-06-30	$10,840,241	1,539,807	-43.7%	Shares	Sole	2023-08-14
2023-03-31	$16,714,430	2,735,586	+72771.2%	Shares	Sole	2023-05-15
2022-12-31	$830,700	130,000	-76.1%	Call	Sole	2023-02-14
2022-12-31	$23,988	3,754	-99.8%	Shares	Other	2023-02-14
2022-09-30	$5,221,100	545,000	+102.2%	Call	Sole	2022-11-15
2022-09-30	$16,703,036	1,743,532	+15.5%	Shares	Other	2022-11-15
2022-06-30	$2,976,384	269,600	-67.9%	Call	Sole	2022-08-15
2022-06-30	$16,668,070	1,509,789	+38.0%	Shares	Sole	2022-08-15
2022-03-31	$18,215,499	1,094,024	+37.3%	Shares	Sole	2022-05-16
2022-03-31	$13,986,000	840,000	+33.3%	Call	Sole	2022-05-16
2021-12-31	$12,026,700	630,000	+4.1%	Call	Sole	2022-02-14
2021-12-31	$15,211,580	796,835	-17.3%	Shares	Sole	2022-02-14
2021-09-30	$14,919,300	605,000	+830.8%	Call	Sole	2021-12-01
2021-09-30	$23,758,923	963,460	+58.2%	Shares	Sole	2021-12-01
2021-06-30	$1,691,300	65,000	-1.5%	Call	Sole	2021-08-16
2021-06-30	$15,849,406	609,124	+264.1%	Shares	Sole	2021-08-16
2021-03-31	$5,297,097	167,312	-61.8%	Shares	Sole	2021-05-17
2020-12-31	$3,062,400	66,000	-92.0%	Call	Sole	2021-02-16
2020-09-30	$27,159,000	825,000	+5400.0%	Call	Sole	2020-11-16
2020-09-30	$14,414,482	437,864	+23.1%	Shares	Sole	2020-11-16
2020-09-30	$9,876,000	300,000	—	Put	Sole	2020-11-16
2020-06-30	$411,750	15,000	-92.7%	Call	Sole	2020-08-14
2020-03-31	$6,143,688	205,200	—	Call	Sole	2020-05-15
2020-03-31	$10,652,023	355,779	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.